Asthma
2 competing products in clinical development for Asthma.
Pipeline by Phase
Phase 31
Approved1
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Dulera | Merck | Approved | Completed | 85 |
| Roflumilast | AstraZeneca | Phase 3 | Completed | 77 |
2 competing products in clinical development for Asthma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Dulera | Merck | Approved | Completed | 85 |
| Roflumilast | AstraZeneca | Phase 3 | Completed | 77 |